ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2017 American Transplant Congress

    Even Non-Donor-Specific HLA-Antibodies Are Associated with a Progressive Decline in Kidney Transplant Function.

    T. Mueller, K. Gerritsen, R. van Breemen, B. Ruesi, S. von Moos, P. Cippa.

    University Spital Zuerich, Zuerich, Switzerland

    Donor-specific anti-HLA-Antibodies (DSA) have been shown to be associated with antibody-mediated rejection episodes and a poorer long-term kidney graft function. The impact of anti-HLA-antibodies without…
  • 2017 American Transplant Congress

    Kidney Waitlist Management: The Readiness Model of Predicting Transplants Under the Kidney Allocation System.

    N. Elias, B. Kimball, L. Walsh, D. Wojciechowski, J. Markmann, E. Heher.

    Transplant Center, Massachusetts General Hospital, Boston, MA

    Based on the Organ Procurement and Transplantation Network data, between 2001 and 2016 the national kidney wait-list has grown from 51,271 to 100,791 (97%). At…
  • 2017 American Transplant Congress

    It's Never too Early to Test: Frequent Anti-A2 Titer Monitoring in Blood Group B Patients is Necessary.

    S. Radomski, S. Rosen-Bronson, B. Diedrich, A. Langeberg, D. Li, M. Awwad, M. Grafals, M. Cooper, A. Gilbert.

    Medstar Georgetown Transplant Institute, Washington, DC

    Introduction:With the implementation of the new Kidney Allocation System (KAS), deceased donor transplants from blood group A2 donors can now be implanted into blood group…
  • 2017 American Transplant Congress

    Biological Interplay Between Circulating HLA-sp Alloreactive Memory B-Cells and Long-Lived Plasma Cells in Kidney Transplant Patients Undergoing Chronic ABMR.

    S. Luque,2 M. Lúcia,4 M. Jarque,2 E. Crespo,2 E. Melilli,1 J. Martorell,3 J. Cruzado,1,2 J. Torras,1,2 J. Grinyó,1,2 O. Bestard.1,2

    1Kidney Transplant Unit, Bellvitge University Hospital, Barcelona, Spain; 2Experimental Nephrology Laboratory, IDIBELL, Barcelona, Spain; 3Immunogenetics Laboratory, Hospital Clínic, Barcelona, Spain; 4Transplant Immunology, School of Medicine, Stanford

    Alloreactive humoral responses are one of the main causes of immune-mediated allograft injury in kidney transplantation. Different biological compartments are involved in the generation and…
  • 2017 American Transplant Congress

    Sirolimus Prolonged Survival After Living Donor Liver Transplantation for HCC Beynd Milan Criteria; Outcome of a Multicenter Prospective Randomized Phase II Trial (ClinicalTrials.gov Identifier: NCT01374750).

    K.-W. Lee,1 S.-H. Kim,2 N.-J. Yi,1 S.-K. Hong,1 G. Yoon,1 H. Kim,1 D. Oh,1 S.-S. Han,2 S.-J. Park,2 K.-S. Suh.1

    1Department of Surgery, Seoul National University, Seoul, Republic of Korea; 2Center for Liver Cancer, National Cancer Center, Goyangsi, Republic of Korea

    Background:It is unclear whether the reported benefit of mTORi in LT for HCC is from direct effect of mTOR inhibitors. We aimed to compare directly…
  • 2017 American Transplant Congress

    Autophagy Regulates LG3 Maturation and Export in Apoptotic Exosome-Like Vesicles.

    D. Beillevaire,1,2,4 M. Francis,1,2,4 G. Diane,2 B. Éric,3,4 D. Mélanie,1,2,4 H. Marie-Josée.1,2,4

    1CRCHUM, Montréal, Canada; 2Université de Montréal, Montréal, Canada; 3CHUL, Québec, Canada; 4CNTRP, Edmonton, Canada

    Background: Autoantibodies to apoptotic antigens such as LG3 – a C-terminal fragment of perlecan– are present pre-transplantation and contribute to organ rejection in renal transplant…
  • 2017 American Transplant Congress

    Post-Donation Remaining Donor Kidney Function as Measured by CKD-EPI Formula at 2 Years Correlates and Is Predicted by Remaining Donor Kidney Volume.

    S. Hussain, A. Diez, A. Khalil, M. Yaqub, D. Mishear, T. Taber, O. Adebiyi, C. Sundaram, W. Goggins, J. Powelson, A. Sharfuddin.

    Indiana University School of Medicine, Indianapolis

    Aim: The aim of our study was to evaluate whether preserved kidney volume correlates with and can predict donor renal function at 2-years post-donation using…
  • 2017 American Transplant Congress

    De Novo Use of Everolimus Reduces Late-Onset Cytomegalovirus Primary Disease Occurring After Antiviral Prophylaxis Discontinuation in Kidney Transplant Recipients.

    A. Devresse,1 V. Avettand-Fenoel,2 A. Scemla,3 L. Morin,3 X. Lebreton,3 C. Tinel,3 L. Amrouche,3 L. Lamhaut,4 M.-O. Timsit,5 J. Zuber,3 C. Legendre,3 D. Anglicheau.3

    1Nephrology Unit, Cliniques Universitaires Saint-Luc, Brussels, Belgium; 2Virology Unit, Hôpital Necker-Enfants Malades, AP-HP, Paris, France; 3Kidney Transplantation and Intensive Care Unit, Hôpital Necker-Enfants Malades, AP-HP, Paris, France; 4Anesthesia Unit, Hôpital Necker-Enfants Malades, AP-HP, Paris, France; 5Urology Unit, Hôpital Necker-Enfants Malades, AP-HP, Paris, France

    Background: Donor (D)+/recipient (R)- serostatus is critically associated with an higher risk of cytomegalovirus (CMV) infection and disease. Antiviral prophylaxis is conventionally used in such…
  • 2017 American Transplant Congress

    The Impact of Social Support on Kidney Transplant Listing Decisions: Results from a Discrete Choice Experiment.

    K. Ladin,1,2 J. Emerson,2 Z. Butt, E. Gordon, D. Hanto, T. Lavelle.2

    1Occupational Therapy, Tufts University, Medford, MA; 2Public Health and Community Medicine, Tufts University School of Medicine, Boston, MA

    Background: Although the Centers for Medicare and Medicaid Services require that social support be used to determine transplant eligibility, guidance is vague and centers vary…
  • 2017 American Transplant Congress

    A Prospective Iterative Trial of Carfizomib-Based Desensitization Trial: Initial Comparative Observations.

    S. Tremblay,1 A. Shields,1,2 R. Alloway,1 P. Brailey,1 A. Leino,1 A. Lichvar,1 B. Abu Jawdeh,1 J. Driscoll,1 A. Girnita,1 E. Woodle.1

    1U of Cincinnati, Cincinnati; 2Christ Hospital, Cincinnati

    Carfilzomib (CFZ) is a 2nd generation proteasome inhibitor different form bortezomib in that it irreversibly disables 20s and 26s proteasomes.Results from the first 2 phases…
  • « Previous Page
  • 1
  • …
  • 53
  • 54
  • 55
  • 56
  • 57
  • …
  • 181
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences